Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
escitalopram oxalate, Quantity: 25.47 mg
Ipca Pharma (Australia) Pty Ltd
escitalopram oxalate
Tablet, film coated
Excipient Ingredients: microcrystalline cellulose; colloidal anhydrous silica; titanium dioxide; purified talc; croscarmellose sodium; magnesium stearate; hypromellose; macrogol 400
Oral
14, 28, 98, 56
(S4) Prescription Only Medicine
Treatment of major depression.,Treatment of social anxiety disorder (social phobia).,Treatment of generalised anxiety disorder.,Treatment of obsessive-compulsive disorder.
Visual Identification: White to off-white, oval, biconvex, film-coated tablet with 'C3' embossed on one side and a notch break-line on the other side.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 48 Months; Container Temperature: Store below 30 degrees Celsius
Licence status A
2012-09-25